Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Bupivacaine-Dexmedetomidine Compared to Intrathecal Bupivacaine-Neostigmine in Elective Caesarean Sections, Randomized Clinical Trial

NCT06055101 is registered in ClinicalTrials.gov with Reham Ali Abdelhaleem Abdelrahman as lead sponsor.

NCT NCT06055101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06055101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Bupivacaine-Dexmedetomidine Compared to Intrathecal Bupivacaine-Neostigmine in Elective Caesarean Sections, Randomized Clinical Trial
Lead sponsor
Reham Ali Abdelhaleem Abdelrahman
Phase
Not applicable
Overall status
Completed
Start date
January 3, 2019
Completion date
April 4, 2023
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, obstetric